Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor

Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein

Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083

Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction

Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,066

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors

Ponte, P. A., Gonzalez‐DeWhitt, P. A., Schilling, J., Miller, J., Hsu, D. K., Greenberg, B., Davis, K. L., Wallace, W., Lieberburg, I. M., Fuller, F. H., et al. (1988) · Nature · doi:10.1038/331525a0 · Cited by 1,050

Carboxy terminal of β-amyloid deposits in aged human, canine, and polar bear brains

Tekirian, T. L., Cole, G. M., Russell, M. J., Yang, F., Weikstein, D. R., Patel, E., Snowdon, D. A., Markesbery, W. R., & Geddes, J. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02062-4 · Cited by 62

Synthesis and Biological Evaluation of Clicked Curcumin and Clicked KLVFFA Conjugates as Inhibitors of β-Amyloid Fibril Formation

Ouberai, M. M., Dumy, P., Chierici, S., & Garcia, J. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900281b · Cited by 64

Degradation of Amyloid β Protein by Purified Myelin Basic Protein

Liao, M.-C., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050856 · Cited by 64

Amyloid β-Protein Stimulates the Expression of Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPAR) in Human Cerebrovascular Smooth Muscle Cells

Davis, J., Wagner, M. R., Zhang, W., Xu, F., & Nostrand, W. E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301398200 · Cited by 60

Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats

Li, W., Deng, Y., Li, F., Liu, B., Liu, H.-Y., Shi, J., & Gong, Q. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.09.001 · Cited by 60

Aggregation of liposomes induced by the toxic peptides Alzheimer’s Aβs, human amylin and prion (106–126): facilitation by membrane-bound GM1 ganglioside

Kurganov, B. I., Doh, M., & Arispe, N. J. (2004) · Peptides · doi:10.1016/j.peptides.2004.01.001 · Cited by 59

A Biotechnological Method Provides Access to Aggregation Competent Monomeric Alzheimer's 1–42 Residue Amyloid Peptide

Döbeli, H., Draeger, N., Huber, G., Jakob, P., Schmidt, D., Seilheimer, B., Stüber, D., Wipf, B., & Zulauf, M. (1995) · Nature Biotechnology · doi:10.1038/nbt0995-988 · Cited by 60

Unifying features of systemic and cerebral amyloidosis

Ghiso, J. A., Wısnıewskı, T., & Frangione, B. (1994) · Molecular Neurobiology · doi:10.1007/bf02778007 · Cited by 60

Two conformational states of amyloid β-peptide: implications for the pathogenesis of Alzheimer's disease

Soto, C. A., & Frangione, B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11299-c · Cited by 60

In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques

Burgold, S., Filser, S., Dorostkar, M. M., Schmidt, B., & Herms, J. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-30 · Cited by 59

Self-Assembly of β-Amyloid 42 Is Retarded by Small Molecular Ligands at the Stage of Structural Intermediates

Bohrmann, B., Adrian, M., Dubochet, J., Kuner, P., Müller, F., Huber, W., Nordstedt, C., & Döbeli, H. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4241 · Cited by 58

Aβ42 pentamers/hexamers are the smallest detectable oligomers in solution

Wolff, M., Zhang-Haagen, B., Decker, C., Barz, B., Schneider, M., Biehl, R., Rădulescu, A., Strodel, B., Willbold, D., & Nagel‐Steger, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-02370-3 · Cited by 58

Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment

Wiley, J. C., Hudson, M. P., Kanning, K. C., Schecterson, L. C., & Bothwell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03266.x · Cited by 60

β-Amyloid peptide-induced morphological changes coincide with increased K+ and Cl− channel activity in rat cortical astrocytes

Jalonen, T. O., Charniga, C. J., & Wielt, D. B. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01189-4 · Cited by 59

Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.

Price, D. L., Borchelt, D., & Sisodia, S. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6381 · Cited by 60

β-Amyloid precursor protein and alzheimer's disease: The peptide plot thickens

Mattson, M. P., & Rydel, R. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90068-9 · Cited by 57

Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies

Vignini, A., Giulietti, A., Nanetti, L., Raffaelli, F., Giusti, L., Mazzanti, L., & Provinciali, L. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309030003 · Cited by 57

Thermodynamically stable amyloid-β monomers have much lower membrane affinity than the small oligomers

Sarkar, B., Das, A. K., & Maiti, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00084 · Cited by 56

Molecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs

Azizeh, B. Y., Head, E., Ibrahim, M. A., Torp, R., Tenner, A. J., Kim, R. C., Lott, I. T., & Cotman, C. W. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7359 · Cited by 58

Racemization: Its Biological Significance on Neuropathogenesis of Alzheimer's Disease.

Mori, H., Ishii, K., Tomiyama, T., Furiya, Y., Sahara, N., Asano, S., Endo, N., Shirasawa, T., & Takio, K. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.174.251 · Cited by 56

The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer’s disease

Lee, J. H., Barral, S., & Reitz, C. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0060-8 · Cited by 57

Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer’s Disease

Zhu, C., Xu, B., Sun, X., Zhu, Q., & Sui, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0269-5 · Cited by 59

Aggregation and neurotoxicity of mutant amyloid β (Aβ) peptides with proline replacement: importance of turn formation at positions 22 and 23

Morimoto, A., Irie, K., Murakami, K., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., & Shirasawa, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00670-8 · Cited by 56

Transgenic mouse models of neurodegenerative disease: Opportunities for therapeutic development

Jankowsky, J. L., Savonenko, A. V., Schilling, G., Wang, J., Xu, G. M., & Borchelt, D. (2002) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-002-0073-7 · Cited by 57

Amyloid β up‐regulates brain‐derived neurotrophic factor production from astrocytes: Rescue from amyloid β‐related neuritic degeneration

Kimura, N., Takahashi, M., Tashiro, T., & Terao, K. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20984 · Cited by 55

CD measurements of β‐amyloid (1–40) and (1–42) in the condensed phase

Harada, T., & Kuroda, R. (2010) · Biopolymers · doi:10.1002/bip.21543 · Cited by 55

β-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease

Dumery, L., Bourdel, F., Soussan, Y., Fialkowsky, A., Viale, S., Nicolas, P., & Reboud‐Ravaux, M. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(00)00009-2 · Cited by 55

Fibrillogenesis of Alzheimer Aβ peptides studied by fluorescence energy transfer

Huang, T. H. J., Fraser, P. E., & Chakrabartty, A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1050 · Cited by 55

Synthesis of Aβ[1‐42] and its derivatives with improved efficiency

Zarándi, M., Soós, K., Fülöp, L., Bozsó, Z., Datki, Z., Tóth, G. K., & Penke, B. (2006) · Journal of Peptide Science · doi:10.1002/psc.801 · Cited by 54

Investigation of the Mechanism of β-Amyloid Fibril Formation by Kinetic and Thermodynamic Analyses

Lin, M., Chen, L.-Y., Tsai, H.-T., Wang, S. S. ‐., Chang, Y., Higuchi, A., & Chen, W. (2008) · Langmuir · doi:10.1021/la703369b · Cited by 54

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD

Li, N., Liu, K., Qiu, Y., Ren, Z., Dai, R., Deng, Y., & Qing, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00051 · Cited by 62

Activation of complement and contact system in Alzheimer's disease

Bergamaschini, L. C., Donarini, C., Gobbo, G. F. D., Parnetti, L., & Gallai, V. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00311-6 · Cited by 54

Proinflammatory cytokine interferon‐γ increases induction of indoleamine 2,3‐dioxygenase in monocytic cells primed with amyloid β peptide 1–42: implications for the pathogenesis of Alzheimer’s disease

Yamada, A., Akimoto, H., Kagawa, S., Guillemin, G. J., & Takikawa, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06175.x · Cited by 58

Stable activity of a deubiquitylating enzyme (Usp2-cc) in the presence of high concentrations of urea and its application to purify aggregation-prone peptides

Shahnawaz, M., Thapa, A., & Park, I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.186 · Cited by 53

Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine 1H-MR spectroscopy study

Lyros, E., Ragoschke-Schumm, A., Kostopoulos, P., Sehr, A., Backens, M., Kalampokini, S., Decker, Y., Lesmeister, M., Liu, Y., Reith, W., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.11.012 · Cited by 48

Toxicity of Pyroglutaminated Amyloid β‐Peptides 3(pE)‐40 and ‐42 Is Similar to That of Aβ1‐40 and ‐42

Tekirian, T. L., Yang, A., Glabe, C. G., & Geddes, J. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731584.x · Cited by 53

Mass and physical dimensions of two distinct populations of paired helical filaments

Ksiȩżak-Reding, H., & Wall, J. S. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90140-6 · Cited by 53

Recent Advances in the Genetics of Alzheimer's Disease and Vascular Dementia with an Emphasis on Gene‐Environment Interactions

Plassman, B. L., & Breitner, J. C. S. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01377.x · Cited by 53

Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils.

Goldfarb, L. G., Brown, P., Haltia, M., Ghiso, J. A., Frangione, B., & Gajdusek, D. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4451 · Cited by 53

Beta amyloid peptide: from different aggregation forms to the activation of different biochemical pathways

Carlo, M. D. (2009) · European Biophysics Journal · doi:10.1007/s00249-009-0439-8 · Cited by 56

The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function

Liu, C.-H., Bu, X., Wang, J., Zhang, T., Xiang, Y., Shen, L., Wang, Q.-H., Deng, B., Wang, X., Zhu, C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151079 · Cited by 53

The Effect of Cholesterol and Monosialoganglioside (GM1) on the Release and Aggregation of Amyloid β-Peptide from Liposomes Prepared from Brain Membrane-like Lipids

Tashima, Y., Oe, R., Lee, S., Sugihara, G., Chambers, E. J., Takahashi, M., & Yamada, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308622200 · Cited by 52

Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism

Samman, W. A., Selim, S., Fayoumi, H. M. E., El-Sayed, N. M., Mehanna, E. T., & Hazem, R. M. (2023) · Pharmaceuticals · doi:10.3390/ph16050753 · Cited by 54

Label-free electrochemical detection of Amyloid beta aggregation in the presence of iron, copper and zinc

Hung, V. W. S., Masoom, H., & Kerman, K. (2012) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2012.05.023 · Cited by 51

The use of mass spectrometry to study amyloid‐β peptides

Grasso, G. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20281 · Cited by 51

The Cu(II)/Aβ/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity

Rózga, M., & Bal, W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900358j · Cited by 54

Toxicity of recombinant β‐amyloid prefibrillar oligomers on the morphogenesis of the sea urchin Paracentrotus lividus

Carrotta, R., Carlo, M. D., Manno, M., Montana, G., Picone, P., Romancino, D. P., & Biagio, P. L. S. (2006) · The FASEB Journal · doi:10.1096/fj.06-5716fje · Cited by 50

Brain Amyloid — A Physicochemical Perspective

Maggie, J. E., & Mantyh, P. W. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00797.x · Cited by 51

Targeted proteomics in Alzheimer’s disease: focus on amyloid-β

Portelius, E., Zetterberg, H., Gobom, J., Andréasson, U., & Blennow, K. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.225 · Cited by 52

A specific structural interaction of Alzheimer's peptide Aβ1–42 with α1-antichymotrypsin

Janciauskiene, S. M., Eriksson, S., & Wright, H. T. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-668 · Cited by 51

Aβ(1–40) Prevents Heparanase-catalyzed Degradation of Heparan Sulfate Glycosaminoglycans and Proteoglycans in Vitro

Bame, K. J., Danda, J., Hassall, A., & Tumova, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17005 · Cited by 51

Amyloid precursor protein, copper and Alzheimer's disease

Multhaup, G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)86907-7 · Cited by 51

Basement membranes, microfibrils and β amyloid fibrillogenesis in Alzheimer's disease: high resolution ultrastructural findings

Inoué, S., Kuroiwa, M., & Kisilevsky, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00055-1 · Cited by 50

Diseases of protein aggregation and the hunt for potential pharmacological agents

Wang, S. S. ‐., Wu, J. W., Yamamoto, S., & Liu, H. (2007) · Biotechnology Journal · doi:10.1002/biot.200700065 · Cited by 49

Controlled in situ preparation of Aβ(1–42) oligomers from the isopeptide “iso-Aβ(1–42)”, physicochemical and biological characterization

Bozsó, Z., Penke, B., Simon, D., Laczkó, I., Juhász, G., Szegedi, V., Kasza, Á., Soós, K., Hetényi, A., Wéber, E., et al. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.001 · Cited by 48

Localization of a Fibrillar Amyloid β-Protein Binding Domain on Its Precursor

Nostrand, W. E. V., Melchor, J. P., Keane, D. M., Saporito-Irwin, S. M., Romanov, G. A., Davis, J., & Xu, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204676200 · Cited by 47

Antibody concentrations to Aβ1–42 monomer and soluble oligomers in untreated and antibody–antigen-dissociated intravenous immunoglobulin preparations

Klaver, A. C., Finke, J. M., Digambaranath, J. L., Balasubramaniam, M., & Loeffler, D. A. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.10.005 · Cited by 49

Modulation of Fibrillogenesis of Amyloid β(1−40) Peptide with Cationic Gemini Surfactant

Cao, M., Han, Y., Wang, J., & Wang, Y. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075271b · Cited by 49

Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model

Sugarman, M. C., Kitazawa, M., Baker, M. J., Caiozzo, V. J., Querfurth, H. W., & LaFerla, F. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.011 · Cited by 48

Why Congo red binding is specific for amyloid proteins - model studies and a computer analysis approach.

Roterman, I., KrUl, M., Nowak, M., Konieczny, L., Rybarska, J., Stopa, B., Piekarska, B., & Zemanek, G. (2001) · PubMed · Cited by 49

Early detection of Alzheimer's disease using creatine chemical exchange saturation transfer magnetic resonance imaging

Chen, L., van Zijl, P. C. M., Wei, Z., Lu, H., Duan, W., Wong, P. C., Li, T., & Xu, J. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118071 · Cited by 48

Conformational Changes Induced by the A21G Flemish Mutation in the Amyloid Precursor Protein Lead to Increased Aβ Production

Tang, T.-C., Hu, Y., Kienlen-Campard, P., Haylani, L. E., Decock, M., van Hees, J., Fu, Z., Octave, J., Constantinescu, S., & Smith, S. O. (2014) · Structure · doi:10.1016/j.str.2013.12.012 · Cited by 50

Oligomeric aggregates of amyloid β peptide 1–42 activate ERK/MAPK in SH-SY5Y cells via the α7 nicotinic receptor

Young, K. F., Pasternak, S., & Rylett, R. J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.08.002 · Cited by 49

Folding stability of amyloid‐β 40 monomer is an important determinant of the nucleation kinetics in fibrillization

Ni, C., Shi, H., Yu, H., Chang, Y. C., & Chen, Y. (2011) · The FASEB Journal · doi:10.1096/fj.10-175539 · Cited by 51

Fibrillar Amyloid β-Protein Mediates the Pathologic Accumulation of Its Secreted Precursor in Human Cerebrovascular Smooth Muscle Cells

Melchor, J. P., & Nostrand, W. E. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9782 · Cited by 48

The effect of vicinal polar and charged groups on hydrophobic hydration

Cheng, Y., & Rossky, P. J. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(199912)50:7 · Cited by 34

Alzheimer's disease amyloid precursor protein (ApPP): proteolytic processing, secretases and βA4 amyloid production

Evin, G. M., Beyreuther, K. T., & Masters, C. L. (1994) · Amyloid · doi:10.3109/13506129409146118 · Cited by 48

Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates

Choi, Y. S., Hou, S., Choe, L. H., & Lee, K. H. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.05.003 · Cited by 47

Heparin Accelerates the Protein Aggregation via the Downhill Polymerization Mechanism: Multi-Spectroscopic Studies to Delineate the Implications on Proteinopathies

Ahanger, I. A., Parray, Z. A., Nasreen, K., Ahmad, F., Hassan, M. I., Islam, A., & Sharma, A. (2021) · ACS Omega · doi:10.1021/acsomega.0c05638 · Cited by 47

Conformational changes in amyloid-beta (12–28) alloforms studied using action-FRET, IMS and molecular dynamics simulations

Daly, S., Kulesza, A. J., Poussigue, F., Simon, A.-L., Choi, C. M., Knight, G., Chirot, F., MacAleese, L., Antoine, R., & Dugourd, P. (2015) · Chemical Science · doi:10.1039/c5sc01463h · Cited by 47

On the Stability of the Soluble Amyloid Aggregates

Sahoo, B., Nag, S., Sengupta, P., & Maiti, S. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.05.055 · Cited by 47

Aβ Fibrillogenesis: Kinetic Parameters for Fibril Formation from Congo Red Binding

Inouye, H., & Kirschner, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4258 · Cited by 47

Lysophosphatidylcholine modulates fibril formation of amyloid beta peptide

Sheikh, A. M., & Nagai, A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07984.x · Cited by 47

Synthetic dityrosine-linked β-amyloid dimers form stable, soluble, neurotoxic oligomers

Kok, W. M., Cottam, J. M., Ciccotosto, G. D., Miles, L. A., Karas, J. A., Scanlon, D. B., Roberts, B. R., Parker, M. W., Cappai, R., Barnham, K. J., et al. (2013) · Chemical Science · doi:10.1039/c3sc22295k · Cited by 46

Neuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouse

Qian, Y., Yin, J., Hong, J., Li, G., Zhang, B., Liu, C., Wan, Q., & Chen, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0598-3 · Cited by 48

Amyloid-β fibrils assembled on ganglioside-enriched membranes contain both parallel β-sheets and turns

Matsubara, T., Yasumori, H., Ito, K., Shimoaka, T., Hasegawa, T., & Sato, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002787 · Cited by 46

Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain

Zulfiqar, S., Garg, P., & Nieweg, K. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0140 · Cited by 46

Platelets transport β-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer's disease in mouse models

Wu, T., Chen, L., Zhou, L., Xu, J., & Guo, K. (2021) · Aging · doi:10.18632/aging.202662 · Cited by 51

Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: Confocal and immunogold electron microscopic studies

Chronopoulos, S., Laird, D. W., & Ali‐Khan, Z. (1994) · The Journal of Pathology · doi:10.1002/path.1711730412 · Cited by 47

Processing of Alzheimer Aβ-Amyloid Precursor Protein: Cell Biology, Regulation, and Role in Alzheimer Disease

Gandy, S., & Greengard, P. (1994) · International review of neurobiology · doi:10.1016/s0074-7742(08)60302-5 · Cited by 46

Tautomeric Effect of Histidine on the Monomeric Structure of Amyloid β-Peptide(1–40)

Shi, H., Kang, B., & Lee, J. Y. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b08685 · Cited by 47

Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes

Pacheco‐Quinto, J., Clausen, D. M., Pérez‐González, R., Peng, H., Meszaros, A., Eckman, C. B., Levy, E., & Eckman, E. A. (2018) · The FASEB Journal · doi:10.1096/fj.201801319r · Cited by 46

Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes

Brewer, G. J., Herrera, R. A., Philipp, S., Sosna, J., Reyes‐Ruiz, J. M., & Glabe, C. G. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190835 · Cited by 47

Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP)

Lopes, D. H. J., Colin, C., Degaki, T. L., de Sousa, A. C. V., Vieira, M. N. N., Sebollela, A., Martinez, A. M. B., Bloch, C., Ferreira, S. T., & Sogayar, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406108200 · Cited by 46

Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro

Pike, C. J., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(94)01354-k · Cited by 46

APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology

Greenberg, B., Savage, M. J., Howland, D., Ali, S. M., Siedlak, S. L., Perry, G. L., Siman, R., & Scott, R. W. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00001-2 · Cited by 45

Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms

Sreenivasamurthy, S., Laul, M., Zhao, N., Kim, T., & Zhu, D. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10378 · Cited by 49

Identification of a Mutant Amyloid Peptide That Predominantly Forms Neurotoxic Protofibrillar Aggregates

Qahwash, I. M., Weiland, K. L., Lu, Y., Sarver, R. W., Kletzien, R. F., & Yan, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213298200 · Cited by 45

Effect of Synthetic Aβ Peptide Oligomers and Fluorinated Solvents on Kv1.3 Channel Properties and Membrane Conductance

Lioudyno, M., Broccio, M., Sokolov, Y., Rasool, S., Wu, J., Alkire, M. T., Liu, V., Kozak, J. A., Dennison, P. R., Glabe, C. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035090 · Cited by 46

C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta

Hernandez, M. X., Namiranian, P., Nguyen, E., Fonseca, M. I., & Tenner, A. J. (2017) · ASN NEURO · doi:10.1177/1759091416687871 · Cited by 44

Spectroscopic investigation on gel‐forming β‐sheet assemblage of peptide derivatives

Shanmugam, G., Prakash, S., & Rajadas, J. (2003) · Biopolymers · doi:10.1002/bip.10493 · Cited by 45

Amyloidogenicity of recombinant human pro-islet amyloid polypeptide (ProIAPP)

Krampert, M., Bernhagen, J., Schmucker, J., Horn, A., Schmauder, A., Brunner, H., Voelter, W., & Kapurniotu, A. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00034-x · Cited by 45

Stereochemical specificity of Alzheimer's disease ?-peptide assembly

Esler, W. P., Stimson, E. R., Fishman, J. B., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., & Maggio, J. E. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(199905)49:6 · Cited by 47

A Conformation Change in the Carboxyl Terminus of Alzheimer's Aβ(1–40) Accompanies the Transition from Dimer to Fibril as Revealed by Fluorescence Quenching Analysis

Garzon-Rodriguez, W., Vega, A., Sepulveda-Becerra, M., Milton, S. C. F., Johnson, D. A., Yatsimirsky, A. K., & Glabe, C. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000756200 · Cited by 45

The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation☆

Webster, S. D., Tenner, A. J., Poulos, T. L., & Cribbs, D. H. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00020-2 · Cited by 44

Metal effects on the membrane interactions of amyloid-β peptides

Gehman, J. D., O’Brien, C. C., Shabanpoor, F., Wade, J. D., & Separovic, F. (2008) · European Biophysics Journal · doi:10.1007/s00249-007-0251-2 · Cited by 44

Negatively charged hydrophobic nanoparticles inhibit amyloid β-protein fibrillation: The presence of an optimal charge density

Liu, H., Xie, B., Dong, X., Zhang, L., Wang, Y., Liu, F., & Sun, Y. P. (2016) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2016.04.003 · Cited by 44

Tautomeric Effect of Histidine on the Monomeric Structure of Amyloid β-Peptide(1–42)

Shi, H., & Lee, J. Y. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00375 · Cited by 44

Age‐related changes of intracellular Aβ in cynomolgus monkey brains

Kimura, N., Yanagisawa, K., Terao, K., Ono, F., Sakakibara, I., Ishii, Y., Kyuwa, S., & Yoshikawa, Y. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00624.x · Cited by 44

Zinc and Alzheimer's Disease

Fitzgerald, D. J. (1995) · Science · doi:10.1126/science.7604269 · Cited by 43

Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

Hilbich, C., Kisters–Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. T. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580

Human and rodent sequence analogs of Alzheimer's amyloid beta A4 share similar properties and can be solubilized in buffers of pH 7.4.

Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16256.x · Cited by 82

Amyloid βA4 of Alzheimer’s Disease: Structural Requirements for Folding and Aggregation

Hilbich, C., Kisters–Woike, B., Masters, C. L., & Beyreuther, K. T. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_3 · Cited by 2

Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease

Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 644

Structural Determinants of the Alzheimer's Amyloid β‐Peptide

Soto, C. A., Brañes, M. C., Alvarez, J., & Inestrosa, N. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63041191.x · Cited by 153